Credit Suisse’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-1,651,002
| Closed | -$28M | – | 4348 |
|
|
2014
Q4 | $28M | Buy |
1,651,002
+1,565,938
| +1,841% | +$26.5M | 0.02% | 626 |
|
|
2014
Q3 | $1.01M | Sell |
85,064
-83,407
| -50% | -$994K | ﹤0.01% | 2670 |
|
|
2014
Q2 | $950K | Sell |
168,471
-881,351
| -84% | -$4.97M | ﹤0.01% | 2932 |
|
|
2014
Q1 | $3.85M | Buy |
1,049,822
+296,945
| +39% | +$1.09M | ﹤0.01% | 1723 |
|
|
2013
Q4 | $2.53M | Buy |
752,877
+568,755
| +309% | +$1.91M | ﹤0.01% | 2111 |
|
|
2013
Q3 | $778K | Sell |
184,122
-14,346
| -7% | -$60.6K | ﹤0.01% | 2758 |
|
|
2013
Q2 | $912K | Buy |
+198,468
| New | +$912K | ﹤0.01% | 2510 |
|